Co-Diagnostics (CODX) Return on Invested Capital (2021 - 2025)
Historic Return on Invested Capital for Co-Diagnostics (CODX) over the last 5 years, with Q3 2025 value amounting to 0.85%.
- Co-Diagnostics' Return on Invested Capital fell 2000.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.57% for FY2024, which is 1800.0% down from last year.
- Per Co-Diagnostics' latest filing, its Return on Invested Capital stood at 0.85% for Q3 2025, which was down 2000.0% from 0.87% recorded in Q2 2025.
- Over the past 5 years, Co-Diagnostics' Return on Invested Capital peaked at 0.56% during Q2 2021, and registered a low of 0.87% during Q2 2025.
- Over the past 5 years, Co-Diagnostics' median Return on Invested Capital value was 0.42% (recorded in 2023), while the average stood at 0.27%.
- Per our database at Business Quant, Co-Diagnostics' Return on Invested Capital crashed by -6000bps in 2023 and then tumbled by -1300bps in 2024.
- Co-Diagnostics' Return on Invested Capital (Quarter) stood at 0.32% in 2021, then crashed by -152bps to 0.16% in 2022, then plummeted by -161bps to 0.43% in 2023, then crashed by -59bps to 0.68% in 2024, then fell by -25bps to 0.85% in 2025.
- Its last three reported values are 0.85% in Q3 2025, 0.87% for Q2 2025, and 0.75% during Q1 2025.